In summary, our data disclose the role of NAT10 in DTIC resistance of melanoma cells, elucidate the machinery through mediating ac4C modification of DDX41 and ZNF746 mRNAs, and shed light on developing new therapeutic strategies using Remodelin and DTIC for melanoma treatment. This evidence concerns the gene DDX41 and melanoma.